TRAF6 promotes abdominal aortic aneurysm development by activating macrophage pyroptosis via the NLRP3 /Caspase1/ GSDMD pathway
The FASEB Journal · 31.01.2025 · 39 (2)
DOI: 10.1096/fj.202402873r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 20.01.2025. Verfasst von Huoying Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Pyroptosis, TNF Receptor-Associated Factor 6, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Guangzhou Science and technology planning project, GDSTC | Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Abdominal aortic aneurysm represents a critical pathology of the aorta that currently lacks effective pharmacological interventions. TNF receptor‐associated factor 6 (TRAF6) has been established to be involved in cardiovascular diseases such as atherosclerosis, hypertension, and heart failure. However, its role in abdominal aortic aneurysm (AAA) remains unclear. This study aimed to explore the role of TRAF6 on AAA formation and its underlying mechanisms. Single‐cell RNA sequencing of human AAA tissues demonstrated that TRAF6 was significantly upregulated in aortic macrophages. Moreover, overexpression of TRAF6 promotes AAA formation in elastase‐induced C57BL/6 mice, while TRAF6 pharmacological inhibition could attenuate AAA development. Consistently, inhibition of TRAF6 in macrophages through in vitro methods notably limits their pyroptosis, while also diminishing proinflammatory responses in these cells. Mechanistically, TRAF6 can modulate macrophage pyroptosis through the NLRP3/Caspase1/GSDMD signaling pathway. Our study highlights the crucial role of the TRAF6/NLRP3/Caspase1/GSDMD axis in macrophage pyroptosis and AAA, offering potential biomarkers and therapeutic targets for AAA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, Guangzhou, Guangdong, China.
- Department of Thoracic Cardiovascular Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.
- Department of Emergency Medicine, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People's Hospital, Shenzhen, Guangdong, China.
ORCID-Profile: Huoying Cai, Huaming Li, Xiaoyong Xiao, Siwen Wang, Ruiming Liu, Yuansen Qin, Yu Zhou, Chen Yao
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Guangzhou Science and technology planning project
- GDSTC | Natural Science Foundation of Guangdong Province
- Shenzhen Science and technology planning project
- Futian District Health and Public Welfare Research Project of Shenzhen City
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Cai, H., Li, H., Xiao, X., Wang, S., Liu, R., Qin, Y., Zhou, Y., & Yao, C. (2025). TRAF6 promotes abdominal aortic aneurysm development by activating macrophage pyroptosis via the NLRP3 /Caspase1/ GSDMD pathway. The FASEB Journal, 39(2). https://doi.org/10.1096/fj.202402873r
Vancouver
Cai H, Li H, Xiao X, Wang S, Liu R, Qin Y, et al. TRAF6 promotes abdominal aortic aneurysm development by activating macrophage pyroptosis via the NLRP3 /Caspase1/ GSDMD pathway. The FASEB Journal. 2025;39(2). doi:10.1096/fj.202402873r
BibTeX
@article{Cai2025,
author = {Cai, Huoying and Li, Huaming and Xiao, Xiaoyong and Wang, Siwen and Liu, Ruiming and Qin, Yuansen and Zhou, Yu and Yao, Chen},
title = {TRAF6 promotes abdominal aortic aneurysm development by activating macrophage pyroptosis via the NLRP3 /Caspase1/ GSDMD pathway},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {2},
doi = {10.1096/fj.202402873r}
}
EUVIMED